Background: Dexmedetomidine, a highly selective α2-adrenoceptor agonist, is widely used in clinical anaesthesia, and intensive care unit. The aim of this study is to evaluate the hemodynamic and analgesic effects of dexmedetomidine in major abdominal surgeries. Patients and methods: 40 patients for radical cystectomy in the age range of 40 -65 years participated in this prospective, randomized, double blinded, placebo controlled clinical study. Patients were randomly assigned to receive either Dexmeditomidine (Dex group) or normal saline (0.9%) (Control group).patients hemodynamics, Recovery profile, and Pain intensity were evaluated. Results Intraoperative mean arterial pressure and heart rate were significantly lower but stable in Dex group. Patients in Dex group had lower VAS scores. Conclusion: Dexmedetomidine is effective in attenuating hemodynamic response to surgical stimulation. Patients in Dex group experienced less postoperative pain.
Introduction
Dexmedetomidine, a highly selective α2-adrenoceptor agonist, is widely used in clinical anaesthesia, intensive care unit (ICU) management and pain treatment as a sedative agent 
Aim of the study:-
The aim of this study is to evaluate hemodynamic and analgesic effect of dexmedetomidine in major abdominal or pelvi abdominal surgeries and its impact on post operative recovery profile.
Patients and methods:
This prospective, randomized, double blinded, placebo controlled clinical study was approved by the Ethics and Research Committee of Sohag Faculty of Medicine, Sohag University. It was conducted at Sohag University Hospital between August 2015 and December 2016. Written informed consent was obtained from each patient preoperatively. The study included 40 patients in the age range of 40 -65 years. The Inclusion criteria were as follows:-Patients with an American Society of Anesthesiologists (ASA) physical status of I or II and scheduled for major abdominal or pelvi-abdominal surgery under general anesthesia were included in this study.
Exclusion criteria included the followings:-
A history of drug or alcohol abuse , allergy to any of the study medications , 2nd or 3rd degree heart block , treatment with α 2 agonists or antagonists, chronic use of antipsychotic medications, chronic use of anti-inflammatory drugs , labile hypertension, cardiac dysrhythmias, coronary artery disease, renal, hepatic or cognitive impairment. Patients were randomly assigned to receive either Dexmeditomidine (Dex group) or normal saline (0.9%) (Control group). Randomization and enrollment were done using sequentially numbered closed envelops. All patients assessment were performed by an anesthetist blinded to the drug used for the study and to reduce the selection and pretest biases another anesthetist prepared the study drug and wrapped the syringe pumps and tubing. All patients were premeditated with atropine (0.02 mg IM) and midazolam 5mg IM. Upon arrival to operative room, base line measurements of mean arterial blood pressure (MAP), heart rate (HR), and oxygen saturation were obtained. Electrocardiographic (ECG) leads were applied for continuous ECG monitoring using a Life Scope Monitor (BSM-2353, Nihon Kohden -Japan). Two large bore intravenous cannulas were inserted in the right and left forearms. After complete aseptic conditions central venous line was inserted in the right internal jugular or subclavian vein using Seldinger ҆ s technique for rapid infusion of fluids if needed. Radial artery on either side was cannulated after doing Allen ҆ s test (to make sure that there is adequate blood supply for the wrist and hand by the ulnar artery) for continuous blood pressure monitoring.
Patients were randomly divided into two groups:-Patients in the dexmedetomidine group (Dex group) received a loading dose of dexmedetomidine at 1 µg/kg in 20 ml of normal saline infused IV over 10 minutes followed by a maintenance infusion of 0.5 µg/kg/h till the end of surgery, and patients in the control group received 20 ml of normal saline infused IV over 10 minutes followed by a maintenance infusion of normal saline till the end of surgery. Induction of general anesthesia in both groups was done by propofol (1.5-2 mg/kg) and fentanyl (2-5 µg/kg). Rocuronium (1 mg/kg) was used to facilitate endotracheal intubation. Patients were ventilated with an oxygen -air mixture (FiO2 = 0.4) with EtCO2 stabilized at 30-35 mmHg. Anesthesia was maintained by inhalational route with Sevoflourane in both groups. All patients in both groups received ondansetron 4 mg prior to the end of surgery. Patients were awakened and extubated in the operative room and were transferred to the PACU upon following simple commands. In the PACU, all patients received rescue morphine as indicated by visual analogue score ≥4. Data collection and measurements:-Patient characteristics including age , sex , weight, ASA physical status , volume of blood loss and volume of blood transfused in addition to duration of anesthesia (time from the start of induction of anesthesia till discontinuation of inhalational anesthesia, reversal of muscle relaxant and tracheal extubation). And duration of surgery (time from the skin incision till the end of skin closure) were recorded. Baseline measurements of heart rate, non -invasive mean arterial blood pressure, and SpO2 were obtained just prior to the start of the study drug infusions, then heart rate and noninvasive mean arterial blood pressure were recorded one minute before induction of anesthesia, one minutes after endotracheal intubation, intraoperatively every 15 minutes till the end of surgery, after complete recovery and postoperatively every 2 hours during the first 24 hours. Recovery profile were assessed by measuring tracheal extubation time , time to eye opening , time to follow verbal commands , and time to have modified Alderte score ≥9 was recorded.( White P et al, 1999). Pain intensity was evaluated on 10 cm visual analogue scale (VAS) when 0 indicated no pain and 10 indicated sever pain. The visual analogue scale (VAS) was recorded at 10, 30, 60, 90 minutes and at 6, 12, and 24 hours postoperatively. Time to the first request of analgesia (VAS>4) was recorded and the total dose of morphine that was given for each patient in the first 24 hours was recorded.
Results
A total of forty patients were enrolled in this prospective study; twenty patients received dexmedetomidine and twenty patients as control. All patients underwent radical cystectomy with orthotopic diversion. Patients' demographic data, duration of anaesthesia and surgery, volume of blood loss, and volume of blood transfusion did not differ between the two groups (Table 1) . Data are presented as mean ± standard deviation or number (%). Dex group = dexmedetomidine group. *P-value denotes statistical significance.
Intraoperative hemodynamic parameters:
-Intraoperative heart rate (HR). Intraoperative heart rate was significantly lower in Dex group at 30 min, 45 min, 60 min, 75 min, 90 min, 105 min and 120 min as shown in table(2) and figure (1). Data are presented as mean ± standard deviation. Dex group = dexmedetomidine group. *P-value < 0.05 denotes statistical significance versus the control group. Intraoperative mean arterial pressure was significantly lower in Dex group after induction, at 15 min, 45min, 60 min and 120 min as shown in table (3) and figure(2) Data are presented as mean ± standard deviation. Dex group = dexmedetomidine group. *P-value < 0.05 denotes statistical significance versus the control group. Dex group = dexmedetomidine group. *P-value < 0.05 denotes statistical significance versus the control group. Postoperative hemodynamic parameters: Postoperative heart rate (HR). There was no significant difference between either groups in postoperative heart rate. 
Recovery profile:
Recovery profile was evaluated by measuring endotracheal extubation time, time to eye opening, time to following verbal command, and time to have modified Alderet score ≥ 9 which were longer in Dex group than in control group but without statistically significant difference between both groups as shown in table (7) . 
):
Patients receiving dexmedetomidine had significant less VAS score at 60, 90, 120 minutes, and 6 hours postoperatively as shown in table (8) and figure (6). Data are presented as mean ± standard deviation. Dex group = dexmedetomidine group. *P-value < 0.05 denotes statistical significance versus the control group.
Figure (5):
Postoperative visual analogue score (VAS score). Data are presented as mean. Dex group = dexmedetomidine group. *P-value < 0.05 denotes statistical significance versus the control group. Time to first analgesic requirment was prolonged in Dex group than the control group (P-value <0.001). Patients in Dex group required less total dose of morphine in postoperative period than control group (P-value <0.001) as shown in table (8). 
Discussion
Dexmedetomidine is a centrally acting α2-adrenergic agonist reducing norepinephrine turnover and decreasing central sympathetic outflow In the present study, the basal readings of HR and MAP were within normal physiological ranges and with no significant difference between both groups.
Patients received dexmedetomidine had significant lower MAP at induction but with haemodynamic stability. Jaakola et al. showed that dexmedetomidine attenuated the increase in HR and MAP during intubation (Jaakola et al., 1992). HR and MAP were significantly lower in intraoperative period in Patients received dexmedetomidine. These results were in agreement with that reported by (Yacout et al., 2012) . No patient in dexmedetomidine group required intervention for haemodynamic instability. In postoperative period, we found no significant difference between both groups in HR and MAP.
Dexmedetomidine group had lower mean heart rate and mean blood pressure compared to Placebo group after endoscopic sinus surgery (Tang et al, 2015). In comparison between dexmedetomidine and placebo, postoperative changes in mean HR between two groups were a statistically significant in cases of laparoscopic cholecystectomy (Manne et al, 2014 ). In the cardiac surgery patients, no significant hemodynamics difference throughout recovery periods or undesirable hemodynamic effects (Hall et al, 2000) .
We found no significant difference between both groups in extubation time and recovery time. Previous studies suggested that dexmedetomidine was associated with significantly longer times to extubation and recovery from anaesthesia 6. Herroeder, S., Pecher, S., Schonherr, M., Kaulitz. Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded,
Conclusion

